Literature DB >> 9149029

Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases.

S Probst-Cousin1, R Villagran-Lillo, R Lahl, M Bergmann, K W Schmid, F Gullotta.   

Abstract

BACKGROUND: Secretory meningioma is a rare histologic variant characterized by a unique epithelial differentiation of meningothelial cells resulting in the production of hyaline inclusions. Most previous reports have presented single case observations. The authors selected 31 cases for a clinicopathologic study to characterize this type of tumor further.
METHODS: Clinical data were compiled and the extent of peritumoral edema was assessed from preoperative computed tomography or magnetic resonance imaging scans. Preparations of surgical specimens of all tumors were studied after both conventional histologic and immunohistochemical preparations were made. Immunostaining was performed by either the avidin-biotin complex method or the alkaline phosphatase-antialkaline phosphatase method using 22 primary antibodies.
RESULTS: In the tumor collection used in this study, secretory meningiomas represented 3% of meningiomas. The female-to-male ratio was 9:1. Most tumors were located at the sphenoid ridge or at the frontal convexity, and recurrences were not observed. Eighty-four percent of tumors presented with slight to marked peritumoral edema. The MIB-1 staining index showed a mean of 3.8%. Inclusions and surrounding cells consistently expressed epithelial membrane antigen, cytokeratins, carcinoembryonic antigen, and carbohydrate antigen 19-9. In decreasing frequency, they also contained alpha1-antitrypsin, immunoglobulin (Ig)A, alpha1-antichymotrypsin, IgM, and IgG. Cells positive for vimentin and S-100 did not contain inclusions. All tumors were positive for progesterone receptors. Macrophages were stained with antibodies to factor XIIIa, human leukocyte antigen-DR, and alpha1-antitrypsin. In 64% of cases, tumor vessels lacked expression of glucose transporter protein 1.
CONCLUSIONS: The classification of secretory meningioma as a distinct variant has been justified on clinical, histologic, and immunohistochemical grounds. The unique epithelial features call attention to the broad spectrum of differentiation properties found in meningiomas.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9149029     DOI: 10.1002/(sici)1097-0142(19970515)79:10<2003::aid-cncr23>3.0.co;2-x

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  14 in total

1.  Distinguishing chordoid meningiomas from their histologic mimics: an immunohistochemical evaluation.

Authors:  Ankur R Sangoi; Mohanpal S Dulai; Andrew H Beck; Daniel J Brat; Hannes Vogel
Journal:  Am J Surg Pathol       Date:  2009-05       Impact factor: 6.394

2.  Clinical features, surgical management, and prognostic factors of secretory meningiomas: a single-center case series of 149 patients.

Authors:  Xiaogang Tao; Kun Wang; Jinqian Dong; Zonggang Hou; Zhen Wu; Junting Zhang; Baiyun Liu
Journal:  J Neurooncol       Date:  2017-11-15       Impact factor: 4.130

3.  Secretory Meningioma Mimicking Malignancy.

Authors:  R Lakhtakia; G V Ramdas; A Alam; A Mehta
Journal:  Med J Armed Forces India       Date:  2011-07-21

Review 4.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

5.  Secretory meningioma: immunohistochemical findings and evaluation of mast cell infiltration.

Authors:  Wuttipong Tirakotai; Hans-Dieter Mennel; Ilhan Celik; Dieter Hellwig; Helmut Bertalanffy; Thomas Riegel
Journal:  Neurosurg Rev       Date:  2005-07-12       Impact factor: 3.042

6.  Secretory meningiomas: clinical, radiological and pathological findings in 70 consecutive cases at one institution.

Authors:  Dai-Jun Wang; Qing Xie; Ye Gong; Yin Wang; Hai-Xia Cheng; Ying Mao; Ping Zhong; Feng-Ping Huang; Kang Zheng; Yong-Fei Wang; Wei-Min Bao; Bo-Jie Yang; Hong Chen; Li-Qian Xie; Ming-Zhe Zheng; Hai-Liang Tang; Hong-Da Zhu; Xian-Cheng Chen; Liang-Fu Zhou
Journal:  Int J Clin Exp Pathol       Date:  2013-02-15

7.  Reactive hyperplasia of vascular pericytes in meningioma: immunohistochemical and ultrastructural studies of two cases.

Authors:  Masayuki Shintaku; Makoto Ohta; Hideo Chihara
Journal:  Int J Clin Exp Pathol       Date:  2022-08-15

8.  Extremely intricate labyrinthine structures: an electron microscopic observation of peculiar invaginations of the plasma membrane found in secretory meningioma.

Authors:  Masayuki Shintaku
Journal:  Int J Clin Exp Pathol       Date:  2022-08-15

Review 9.  Secretory meningiomas.

Authors:  Nagihan Colakoğlu; Eren Demirtaş; Nezih Oktar; Nilgün Yüntem; Sertaç Islekel; Nurcan Ozdamar
Journal:  J Neurooncol       Date:  2003-05       Impact factor: 4.130

10.  Secretory meningiomas: a benign subgroup causing life-threatening complications.

Authors:  Jan Regelsberger; Christian Hagel; Pedram Emami; Thorsten Ries; Oliver Heese; Manfred Westphal
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.